{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:19:38Z","timestamp":1792783178392,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Research Fund of Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital","award":["2022QN30"],"award-info":[{"award-number":["2022QN30"]}],"id":[{"id":"https:\/\/ror.org\/01qh26a66","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Sichuan Science and Technology Program","award":["2026NSFSC0686"],"award-info":[{"award-number":["2026NSFSC0686"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05664-1","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T08:30:05Z","timestamp":1784881805000},"page":"4321-4335","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["IL-6 enhances oral squamous cell carcinoma progression associated with JAK2\/STAT3-dependent regulation of MMP-10"],"prefix":"10.1007","volume":"481","author":[{"given":"Xiliang","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"5664_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2022.188784","volume":"1877","author":"A Jangholi","year":"2022","unstructured":"Jangholi A, M\u00fcller Bark J, Kenny L, Vasani S, Rao S, Dolcetti R, Punyadeera C (2022) Exosomes at the crossroad between therapeutic targets and therapy resistance in head and neck squamous cell carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1877:188784. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188784","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"key":"5664_CR2","doi-asserted-by":"publisher","first-page":"257","DOI":"10.31083\/j.fbl2907257","volume":"29","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, Zhu X, Li Q, Wang Z, Zuo Q, Liu X, Tan J (2024) M6A-mediated IRS1 regulates the development of oral squamous cell carcinoma through p53\/Line-1 signaling. Front Biosci (Landmark Ed) 29:257. https:\/\/doi.org\/10.31083\/j.fbl2907257","journal-title":"Front Biosci (Landmark Ed)"},{"key":"5664_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/froh.2021.815606","volume":"2","author":"KSR Shetty","year":"2021","unstructured":"Shetty KSR, Kurle V, Greeshma P, Ganga VB, Murthy SP, Thammaiah SK, Prasad PK, Chavan P, Halkud R, Krishnappa R (2021) Salvage surgery in recurrent oral squamous cell carcinoma. Front Oral Health 2:815606. https:\/\/doi.org\/10.3389\/froh.2021.815606","journal-title":"Front Oral Health"},{"key":"5664_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41577-020-0406-2","volume":"21","author":"M Certo","year":"2021","unstructured":"Certo M, Tsai CH, Pucino V, Ho PC, Mauro C (2021) Lactate modulation of immune responses in inflammatory versus tumour microenvironments. Nat Rev Immunol 21:151\u2013161. https:\/\/doi.org\/10.1038\/s41577-020-0406-2","journal-title":"Nat Rev Immunol"},{"key":"5664_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cells12162048","author":"I Fiorilla","year":"2023","unstructured":"Fiorilla I, Martinotti S, Todesco AM, Bonsignore G, Cavaletto M, Patrone M, Ranzato E, Audrito V (2023) Chronic inflammation, oxidative stress and metabolic plasticity: three players driving the pro-tumorigenic microenvironment in malignant mesothelioma. Cells. https:\/\/doi.org\/10.3390\/cells12162048","journal-title":"Cells"},{"key":"5664_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten FR, Grivennikov SI (2019) Inflammation and cancer: triggers, mechanisms, and consequences. Immunity 51:27\u201341. https:\/\/doi.org\/10.1016\/j.immuni.2019.06.025","journal-title":"Immunity"},{"key":"5664_CR7","doi-asserted-by":"publisher","first-page":"11553","DOI":"10.1007\/s13277-016-5098-7","volume":"37","author":"N Kumari","year":"2016","unstructured":"Kumari N, Dwarakanath BS, Das A, Bhatt AN (2016) Role of interleukin-6 in cancer progression and therapeutic resistance. Tumour Biol 37:11553\u201311572. https:\/\/doi.org\/10.1007\/s13277-016-5098-7","journal-title":"Tumour Biol"},{"key":"5664_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-024-02422-5","volume":"41","author":"AH Mohamed","year":"2024","unstructured":"Mohamed AH, Ahmed AT, Al Abdulmonem W, Bokov DO, Shafie A, Al-Hetty H, Hsu CY, Alissa M, Nazir S, Jamali MC, Mudhafar M (2024) Interleukin-6 serves as a critical factor in various cancer progression and therapy. Med Oncol 41:182. https:\/\/doi.org\/10.1007\/s12032-024-02422-5","journal-title":"Med Oncol"},{"key":"5664_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.14670\/hh-18-033","volume":"34","author":"L Lacina","year":"2019","unstructured":"Lacina L, Br\u00e1bek J, Kr\u00e1l V, Kodet O, Smetana K Jr (2019) Interleukin-6: a molecule with complex biological impact in cancer. Histol Histopathol 34:125\u2013136. https:\/\/doi.org\/10.14670\/hh-18-033","journal-title":"Histol Histopathol"},{"key":"5664_CR10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.54439","volume":"16","author":"T Adachi","year":"2024","unstructured":"Adachi T, Goda H, Shinriki S, Tokuzen N, Kuribayashi N, Hino S, Nakashiro KI, Uchida D (2024) Prognostic significance of serum interleukin-6 levels in oral squamous cell carcinoma. Cureus 16:e54439. https:\/\/doi.org\/10.7759\/cureus.54439","journal-title":"Cureus"},{"key":"5664_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4103\/ams.ams_240_22","volume":"13","author":"NAJ Rani","year":"2023","unstructured":"Rani NAJ, Vardhan BGH, Srinivasan S, Gopal SK (2023) Evaluation of salivary interleukin-6 in patients with oral squamous cell carcinoma, oral potentially malignant disorders, chronic periodontitis and in healthy controls - a cross-sectional comparative study. Ann Maxillofac Surg 13:70\u201375. https:\/\/doi.org\/10.4103\/ams.ams_240_22","journal-title":"Ann Maxillofac Surg"},{"key":"5664_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2021.105665","volume":"124","author":"LY Wei","year":"2022","unstructured":"Wei LY, Lin HC, Tsai FC, Ko JY, Kok SH, Cheng SJ, Lee JJ, Chia JS (2022) Effects of interleukin-6 on STAT3-regulated signaling in oral cancer and as a prognosticator of patient survival. Oral Oncol 124:105665. https:\/\/doi.org\/10.1016\/j.oraloncology.2021.105665","journal-title":"Oral Oncol"},{"key":"5664_CR13","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","volume":"15","author":"DE Johnson","year":"2018","unstructured":"Johnson DE, O\u2019Keefe RA, Grandis JR (2018) Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer. Nat Rev Clin Oncol 15:234\u2013248. https:\/\/doi.org\/10.1038\/nrclinonc.2018.8","journal-title":"Nat Rev Clin Oncol"},{"key":"5664_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cells11071164","author":"PB Sehgal","year":"2022","unstructured":"Sehgal PB (2022) Interleukin-6 at the host-tumor interface: STAT3 in biomolecular condensates in cancer cells. Cells. https:\/\/doi.org\/10.3390\/cells11071164","journal-title":"Cells"},{"key":"5664_CR15","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2905192","volume":"29","author":"A La Russa","year":"2024","unstructured":"La Russa A, Serra R, Faga T, Crugliano G, Bonelli A, Coppolino G, Bolignano D, Battaglia Y, Ielapi N, Costa D, Michael A, Andreucci M (2024) Kidney fibrosis and matrix metalloproteinases (MMPs). Front Biosci (Landmark Ed) 29:192. https:\/\/doi.org\/10.31083\/j.fbl2905192","journal-title":"Front Biosci (Landmark Ed)"},{"key":"5664_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1093990","volume":"13","author":"L He","year":"2022","unstructured":"He L, Kang Q, Chan KI, Zhang Y, Zhong Z, Tan W (2022) The immunomodulatory role of matrix metalloproteinases in colitis-associated cancer. Front Immunol 13:1093990. https:\/\/doi.org\/10.3389\/fimmu.2022.1093990","journal-title":"Front Immunol"},{"key":"5664_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010146","author":"S Niland","year":"2021","unstructured":"Niland S, Riscanevo AX, Eble JA (2021) Matrix metalloproteinases shape the tumor microenvironment in cancer progression. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23010146","journal-title":"Int J Mol Sci"},{"key":"5664_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26083824","author":"E Gacuta","year":"2025","unstructured":"Gacuta E, \u0141awicki M, Kulesza M, \u0141awicki P, Kicman A, \u0141ubi\u0144ska E, \u0141awicki S (2025) Plasma levels of matrilysins (MMP-7 and MMP-26) and stromelysins (MMP-3 and MMP-10) in diagnosis of endometrial cancer patients. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26083824","journal-title":"Int J Mol Sci"},{"key":"5664_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s42003-023-04437-6","volume":"6","author":"B Dharavath","year":"2023","unstructured":"Dharavath B, Butle A, Pal A, Desai S, Upadhyay P, Rane A, Khandelwal R, Manavalan S, Thorat R, Sonawane K, Vaish R, Gera P, Bal M, D\u2019Cruz AK, Nair S, Dutt A (2023) Role of miR-944\/MMP10\/AXL- axis in lymph node metastasis in tongue cancer. Commun Biol 6:57. https:\/\/doi.org\/10.1038\/s42003-023-04437-6","journal-title":"Commun Biol"},{"key":"5664_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph191912613","author":"J Kudelski","year":"2022","unstructured":"Kudelski J, M\u0142ynarczyk G, Gudowska-Sawczuk M, Mroczko B, Darewicz B, Bruczko-Goralewska M, Romanowicz L (2022) Higher content but not activity of stromelysin-2 (MMP-10) in comparison to stromelysin-1 (MMP-3) in human renal carcinoma. Int J Environ Res Public Health. https:\/\/doi.org\/10.3390\/ijerph191912613","journal-title":"Int J Environ Res Public Health"},{"key":"5664_CR21","doi-asserted-by":"publisher","first-page":"6306","DOI":"10.3390\/cimb44120430","volume":"44","author":"M Monea","year":"2022","unstructured":"Monea M, Pop AM (2022) The use of salivary levels of matrix metalloproteinases as an adjuvant method in the early diagnosis of oral squamous cell carcinoma: a narrative literature review. Curr Issues Mol Biol 44:6306\u20136322. https:\/\/doi.org\/10.3390\/cimb44120430","journal-title":"Curr Issues Mol Biol"},{"key":"5664_CR22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.4103\/jomfp.jomfp_438_22","volume":"27","author":"JK Savita","year":"2023","unstructured":"Savita JK, Varsha VK, Girish HC (2023) Role of MMP1 and MMP10 in local invasion and distant metastasis in different levels of oral squamous cell carcinoma - a immunohistochemical comparative study. J Oral Maxillofac Pathol 27:315\u2013322. https:\/\/doi.org\/10.4103\/jomfp.jomfp_438_22","journal-title":"J Oral Maxillofac Pathol"},{"key":"5664_CR23","first-page":"4497","volume":"29","author":"X Zhang","year":"2009","unstructured":"Zhang X, Yin P, Di D, Luo G, Zheng L, Wei J, Zhang J, Shi Y, Zhang J, Xu N (2009) IL-6 regulates MMP-10 expression via JAK2\/STAT3 signaling pathway in a human lung adenocarcinoma cell line. Anticancer Res 29:4497\u20134501","journal-title":"Anticancer Res"},{"key":"5664_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136795","author":"E Ferrari","year":"2021","unstructured":"Ferrari E, Pezzi ME, Cassi D, Pertinhez TA, Spisni A, Meleti M (2021) Salivary cytokines as biomarkers for oral squamous cell carcinoma: a systematic review. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22136795","journal-title":"Int J Mol Sci"},{"key":"5664_CR25","doi-asserted-by":"publisher","first-page":"50","DOI":"10.21053\/ceo.2019.00906","volume":"14","author":"U Uz","year":"2021","unstructured":"Uz U, Eskiizmir G (2021) Association between interleukin-6 and head and neck squamous cell carcinoma: a systematic review. Clin Exp Otorhinolaryngol 14:50\u201360. https:\/\/doi.org\/10.21053\/ceo.2019.00906","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"5664_CR26","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s00784-015-1551-z","volume":"20","author":"L Bagan","year":"2016","unstructured":"Bagan L, S\u00e1ez GT, Tormos MC, Labaig-Rueda C, Murillo-Cortes J, Bagan JV (2016) Salivary and serum interleukin-6 levels in proliferative verrucous leukoplakia. Clin Oral Investig 20:737\u2013743. https:\/\/doi.org\/10.1007\/s00784-015-1551-z","journal-title":"Clin Oral Investig"},{"key":"5664_CR27","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s11033-024-09359-y","volume":"51","author":"Z Lu","year":"2024","unstructured":"Lu Z, Liu J, Wan Q, Wu Y, Wu W, Chen Y (2024) Chemerin promotes invasion of oral squamous cell carcinoma by stimulating IL-6 and TNF-\u03b1 production via STAT3 activation. Mol Biol Rep 51:436. https:\/\/doi.org\/10.1007\/s11033-024-09359-y","journal-title":"Mol Biol Rep"},{"key":"5664_CR28","doi-asserted-by":"publisher","first-page":"6609","DOI":"10.7314\/apjcp.2015.16.15.6609","volume":"16","author":"H Kadeh","year":"2015","unstructured":"Kadeh H, Saravani S, Heydari F, Keikha M, Rigi V (2015) Expression of matrix metalloproteinase-10 at invasive front of squamous cell carcinoma and verrucous carcinoma in the oral cavity. Asian Pac J Cancer Prev 16:6609\u20136613. https:\/\/doi.org\/10.7314\/apjcp.2015.16.15.6609","journal-title":"Asian Pac J Cancer Prev"},{"key":"5664_CR29","doi-asserted-by":"publisher","first-page":"6324","DOI":"10.1158\/1078-0432.Ccr-13-3336","volume":"20","author":"X Du","year":"2014","unstructured":"Du X, Lin BC, Wang QR, Li H, Ingalla E, Tien J, Rooney I, Ashkenazi A, Penuel E, Qing J (2014) MMP-1 and pro-MMP-10 as potential urinary pharmacodynamic biomarkers of FGFR3-targeted therapy in patients with bladder cancer. Clin Cancer Res 20:6324\u20136335. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-13-3336","journal-title":"Clin Cancer Res"},{"key":"5664_CR30","first-page":"2791","volume":"27","author":"X Zhang","year":"2007","unstructured":"Zhang X, Zhu S, Luo G, Zheng L, Wei J, Zhu J, Mu Q, Xu N (2007) Expression of MMP-10 in lung cancer. Anticancer Res 27:2791\u20132795","journal-title":"Anticancer Res"},{"key":"5664_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.106839","volume":"141","author":"CA Morcos","year":"2023","unstructured":"Morcos CA, Khattab SN, Haiba NS, Bassily RW, Abu-Serie MM, Teleb M (2023) Battling colorectal cancer via s-triazine-based MMP-10\/13 inhibitors armed with electrophilic warheads for concomitant ferroptosis induction; the first-in-class dual-acting agents. Bioorg Chem 141:106839. https:\/\/doi.org\/10.1016\/j.bioorg.2023.106839","journal-title":"Bioorg Chem"},{"key":"5664_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.124","volume":"3","author":"HQ Wang","year":"2022","unstructured":"Wang HQ, Man QW, Huo FY, Gao X, Lin H, Li SR, Wang J, Su FC, Cai L, Shi Y, Liu B, Bu LL (2022) STAT3 pathway in cancers: past, present, and future. MedComm 3:e124. https:\/\/doi.org\/10.1002\/mco2.124","journal-title":"MedComm"},{"key":"5664_CR33","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12974","volume":"54","author":"Y Liu","year":"2021","unstructured":"Liu Y, Liao S, Bennett S, Tang H, Song D, Wood D, Zhan X, Xu J (2021) STAT3 and its targeting inhibitors in osteosarcoma. Cell Prolif 54:e12974. https:\/\/doi.org\/10.1111\/cpr.12974","journal-title":"Cell Prolif"},{"key":"5664_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2022.110275","volume":"92","author":"M El-Tanani","year":"2022","unstructured":"El-Tanani M, Al Khatib AO, Aladwan SM, Abuelhana A, McCarron PA, Tambuwala MM (2022) Importance of STAT3 signalling in cancer, metastasis and therapeutic interventions. Cell Signal 92:110275. https:\/\/doi.org\/10.1016\/j.cellsig.2022.110275","journal-title":"Cell Signal"},{"key":"5664_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106357","volume":"182","author":"J Yang","year":"2022","unstructured":"Yang J, Wang L, Guan X, Qin JJ (2022) Inhibiting STAT3 signaling pathway by natural products for cancer prevention and therapy: in vitro and in vivo activity and mechanisms of action. Pharmacol Res 182:106357. https:\/\/doi.org\/10.1016\/j.phrs.2022.106357","journal-title":"Pharmacol Res"},{"key":"5664_CR36","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.7150\/jca.91277","volume":"15","author":"H Su","year":"2024","unstructured":"Su H, Yang Y, Li C, Li J, Lv H, Jia X, Yang J, Lei J, Li X, Guo H, Wang Z, Zhang S (2024) Development and validation of matrix metalloproteinase for predicting prognosis and tumour microenvironment immune profiles in uterine corpus endometrial carcinoma. J Cancer 15:4020\u20134039. https:\/\/doi.org\/10.7150\/jca.91277","journal-title":"J Cancer"},{"key":"5664_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111045","volume":"124","author":"L Chang","year":"2023","unstructured":"Chang L, Gao J, Yu Y, Liao B, Zhou Y, Zhang J, Ma X, Hou W, Zhou T, Xu Q (2023) MMP10 alleviates non-alcoholic steatohepatitis by regulating macrophage M2 polarization. Int Immunopharmacol 124:111045. https:\/\/doi.org\/10.1016\/j.intimp.2023.111045","journal-title":"Int Immunopharmacol"},{"key":"5664_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063555","volume":"8","author":"MY Murray","year":"2013","unstructured":"Murray MY, Birkland TP, Howe JD, Rowan AD, Fidock M, Parks WC, Gavrilovic J (2013) Macrophage migration and invasion is regulated by MMP10 expression. PLoS ONE 8:e63555. https:\/\/doi.org\/10.1371\/journal.pone.0063555","journal-title":"PLoS ONE"},{"key":"5664_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.866014","volume":"12","author":"SG Manore","year":"2022","unstructured":"Manore SG, Doheny DL, Wong GL, Lo HW (2022) IL-6\/JAK\/STAT3 signaling in breast cancer metastasis: biology and treatment. Front Oncol 12:866014. https:\/\/doi.org\/10.3389\/fonc.2022.866014","journal-title":"Front Oncol"},{"key":"5664_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1381251","volume":"14","author":"L Long","year":"2024","unstructured":"Long L, Fei X, Chen L, Yao L, Lei X (2024) Potential therapeutic targets of the JAK2\/STAT3 signaling pathway in triple-negative breast cancer. Front Oncol 14:1381251. https:\/\/doi.org\/10.3389\/fonc.2024.1381251","journal-title":"Front Oncol"},{"key":"5664_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02376-4","volume":"41","author":"L Xiao","year":"2022","unstructured":"Xiao L, Li X, Cao P, Fei W, Zhou H, Tang N, Liu Y (2022) Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2\/STAT3\/Sox4\/NLRP3 signaling pathway. J Exp Clin Cancer Res 41:166. https:\/\/doi.org\/10.1186\/s13046-022-02376-4","journal-title":"J Exp Clin Cancer Res"},{"key":"5664_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/cells11193131","author":"M Jiang","year":"2022","unstructured":"Jiang M, Li B (2022) STAT3 and its targeting inhibitors in oral squamous cell carcinoma. Cells. https:\/\/doi.org\/10.3390\/cells11193131","journal-title":"Cells"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05664-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05664-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05664-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:04:01Z","timestamp":1791245041000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05664-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":42,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["5664"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05664-1","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study involving human subjects was conducted in accordance with the World Medical Association Declaration of Helsinki and approved by the Institutional Ethics Committee of Sichuan Provincial People\u2019s Hospital. Informed consent was obtained from all patients included in the study. The animal experimental protocol followed institutional and national guidelines for the care and use of laboratory animals and was approved by the institutional animal care committee of Sichuan Provincial People\u2019s Hospital.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}